Marcia Angell
Datos Biográficos
| ID | 1357366 |
|---|---|
| NOMBRE | Marcia Angell |
| NOMBRES | Marcia |
| APELLIDO | Angell |
| FIRMA | ANGELL M |
| AFILIACIONES | Harvard Medical School, Boston, MA, USA |
| VERIFICADO | No |
| TOTAL DE OBRAS | 10 |
| TOTAL DE CITAS | 3 |
| TOTAL COMO AUTOR | 10 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 1987 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2016 |
| ÍNDICE H | 1 |
Moving Forward From the Affordable Care Act to a Single-Payer System
The authors discuss developments in the effort to achieve universal health care in the U.S. in 2016, particularly the implementation of the Affordable Care Act (ACA). Also cited are the ruling by the Supreme Court upholding the legality of the ACA subsidies, the claim by the Congressional Budget Office that will still be 27 million Americans who will be uninsured under the ACA, and some recommendations to resolve the shortcomings of the ACA in te…
Obamacare Confronts a Fiscal Crisis
This article was written shortly after the U.S. Supreme Court’s decision upholding the Affordable Care Act (Obamacare) and reflects my view of the situation at that time. As it turned out, Obamacare was not much of an issue in the 2012 election campaign, which focused mainly on jobs and fairness for the middle class. Still, I believe that it is extremely unlikely that Obamacare will be fully implemented, for the reasons discussed herein, and that…
When Money Talks and Science Listens
Resolved
Williams, Redford MD; Schneiderman, Neil PhD; Relman, Arnold MD, and; Angell, Marcia MD Author Information
Resolved
From the School of Medicine and Social Medicine, Harvard Medical School, Cambridge, MA. Received for publication September 10, 2001; revision received September 27, 2001. Address reprint requests to: Arnold S. Relman, MD, 13 Ellery Square, Cambridge, MA 02138-4227. Email: [email protected]
The Ethics of Clinical Research in the Third World
An essential ethical condition for a randomized clinical trial comparing two treatments for a disease is that there be no good reason for thinking one is better than the other.1,2 Usually, investigators hope and even expect that the new treatment will be better, but there should not be solid evidence one way or the other. If there is, not only would the trial be scientifically redundant, but the investigators would be guilty of knowingly giving i…
Caring for women's health—what is the problem
Case Studies
Medicine
Angell, a physician, addresses the issue of the impact that cost\ncontainment efforts in health care will have on the physician patient\nrelationship. Some argue that the traditional patient-centered ethic must\ngive way to the public interest in reducing health expenditures, and that\nphysicians ought to cooperate by tailoring the care they deliver to patients\naccording to economic goals. Angell examines three justifications for\nlimiting medic…
The Physician as Manager of Disease
Moving Forward From the Affordable Care Act to a Single-Payer System
The authors discuss developments in the effort to achieve universal health care in the U.S. in 2016, particularly the implementation of the Affordable Care Act (ACA). Also cited are the ruling by the Supreme Court upholding the legality of the ACA subsidies, the claim by the Congressional Budget Office that will still be 27 million Americans who will be uninsured under the ACA, and some recommendations to resolve the shortcomings of the ACA in te…
Medicine
Angell, a physician, addresses the issue of the impact that cost\ncontainment efforts in health care will have on the physician patient\nrelationship. Some argue that the traditional patient-centered ethic must\ngive way to the public interest in reducing health expenditures, and that\nphysicians ought to cooperate by tailoring the care they deliver to patients\naccording to economic goals. Angell examines three justifications for\nlimiting medic…
The Physician as Manager of Disease
Case Studies
Caring for women's health—what is the problem
The Ethics of Clinical Research in the Third World
An essential ethical condition for a randomized clinical trial comparing two treatments for a disease is that there be no good reason for thinking one is better than the other.1,2 Usually, investigators hope and even expect that the new treatment will be better, but there should not be solid evidence one way or the other. If there is, not only would the trial be scientifically redundant, but the investigators would be guilty of knowingly giving i…
Resolved
Williams, Redford MD; Schneiderman, Neil PhD; Relman, Arnold MD, and; Angell, Marcia MD Author Information
Resolved
From the School of Medicine and Social Medicine, Harvard Medical School, Cambridge, MA. Received for publication September 10, 2001; revision received September 27, 2001. Address reprint requests to: Arnold S. Relman, MD, 13 Ellery Square, Cambridge, MA 02138-4227. Email: [email protected]
When Money Talks and Science Listens
Obamacare Confronts a Fiscal Crisis
This article was written shortly after the U.S. Supreme Court’s decision upholding the Affordable Care Act (Obamacare) and reflects my view of the situation at that time. As it turned out, Obamacare was not much of an issue in the 2012 election campaign, which focused mainly on jobs and fairness for the middle class. Still, I believe that it is extremely unlikely that Obamacare will be fully implemented, for the reasons discussed herein, and that…
Moving Forward From the Affordable Care Act to a Single-Payer System
The authors discuss developments in the effort to achieve universal health care in the U.S. in 2016, particularly the implementation of the Affordable Care Act (ACA). Also cited are the ruling by the Supreme Court upholding the legality of the ACA subsidies, the claim by the Congressional Budget Office that will still be 27 million Americans who will be uninsured under the ACA, and some recommendations to resolve the shortcomings of the ACA in te…
Medicine (7 obras) · Law (5 obras) · Political science (5 obras) · Psychology (4 obras) · Disease (3 obras) · Health care (3 obras) · Healthcare Policy and Management (3 obras) · Internal Medicine (3 obras) · Primary Care and Health Outcomes (3 obras) · Psychiatry (3 obras)